Skip to main content
Peter Moses, MD, Gastroenterology, Charlotte, VT, University of Vermont Medical Center

PeterL.MosesMDBiopharma Consultant, PLLC

Gastroenterology Charlotte, VT

Advanced Endoscopic Interventional

Professor Emeritus University of Vermont. Consultant for Biopharma and Life Sciences

Dr. Moses is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moses' full profile

Already have an account?

Summary

  • Dr. Moses is a full professor Emeritus at the Robert Larner College of Medicine, University of Vermont. He is the former Medical Director at Takeda Pharmaceuticals and is actively consulting for Pharma Companies as a expert in the GI space.

    Doctor Moses received his M.D. medical degree from Case Western Reserve University School of Medicine where he was elected to the Alpha-Omega-Alpha honor medical society. His post-graduate training in Internal Medicine, Gastroenterology and Hepatology was at Dartmouth Medical School and the Dartmouth Hitchcock Medical Center. He is the author of many peer reviewed articles in GI Medicine and Endoscopy.

Education & Training

  • MIT Sloane School of Management
    MIT Sloane School of ManagementCertificate, Leadership Enterprise, 2009 - 2009
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Gastroenterology, 1995
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1990 - 1993
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1990
  • Lake Forest College
    Lake Forest CollegeB.A., with Honors, 1981

Certifications & Licensure

  • VT State Medical License
    VT State Medical License 1991 - 2024
  • MA State Medical License
    MA State Medical License 2021 - 2022
  • NY State Medical License
    NY State Medical License 2009 - 2021
  • ABIM GI

Awards, Honors, & Recognition

  • Alpha Omega Alpha AOA Ohio Chapter, 1990
  • Research Award UVMMG, 2016
  • Novartis Motility Award for presentation 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Partially covered self-expandable metal stents vs plastic stents for malinent bilary obstruction: Acost-effectiveness analysis  
    Barkun,A, Martel, M, Alnaamani and Moses, PL, Can Journal of Gastroenter and Hepatology, 1/1/2015
  • Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: A cost effectiveness analysis  
    AN Barkum, V Adam, M Martel, K AlNaamani, PL Moses, Canadian Journal of Gastroenterology and Hepatology, 1/1/2015
  • Randomized trial in malignant biliary obstruction: Plastic vs partially covered metal stents  
    Moses, PL, Martel, M, Alnaamani, A, Stuart, G, Adam, V, Kowalski, T, Mitty, R, Barkun,A, Branch, MS, World Journal of Gastroenterology, 1/1/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Cost effectiveness of partially covered self-expandable metal stents vs. Polyethylene stents for malignant biliary obstruction.
    Moses PL, Annual Scientific Meeting of the AGA, Chicago, IL, 1/1/2013
  • Mucosal serotonin signaling is altered in chronic constipation.
    Costedio MM, Moses PL, Brooks E, Glass L, Wood M, Ganguly EK, Coates MD, Speer C, Hyman NH, Mawe GM, Annual AGA Meeting, 1/1/2008
  • Altered Intestinal Serotonin Signaling in Opiate-Induced Constipation.
    Coates MD, Costedio MM, Ganguly EK, Callahan MJ, Mawe GM, Moses PL, American Journal of Gastroenterology; Annual Scientific Meeting of the American College of Gastroenterology, 1/1/2006
  • Join now to see all

Lectures

  • Manipulating the Gut Microbiota: Therapeutic Potential for Treatment of C. Difficile and Other GI Disorders. 
    Nashua, NH - 1/1/2017
  • Manipulating the Gut Microbiota 
    1/1/2017
  • Serotonin signaling in the human gut. 
    Cambridge, MA - 1/1/2017
  • Join now to see all

Other

  • Discoveries and Breakthroughs Inside Science. 
    Moses PL, Syndicated TV Broadcast: ABC
    Los Angeles, CA - 1/11/2004
  • Atypical Serotonin Concentrations found in Patients with IBS and Ulcerative Colitis – First Molecular Marker for Functional Bowel Disorders Identified 
    Moses PL, Gastroenterology and Endoscopy News
    1/1/2004
  • Featured Article: While Poorly Understood, IBS is uniquely suited to DM Intervention. 
    Moses PL, Managed Healthcare Executive Shelley Rose
    1/1/2004
  • Join now to see all

Committees

  • Member, UVM Professional Standards Committee

Professional Memberships

Hospital Affiliations